The global Anticoagulants Drug market was valued at US$ 30180 million in 2022 and is projected to reach US$ 37520 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Anticoagulants Drug market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Anticoagulants Drug market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Anticoagulants Drug market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
This report aims to provide a comprehensive presentation of the global market for Anticoagulants Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulants Drug. This report contains market size and forecasts of Anticoagulants Drug in global, including the following market information:
- Global Anticoagulants Drug Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global Anticoagulants Drug Market Sales, 2018-2023, 2024-2032, (K Pcs)
- Global top five Anticoagulants Drug companies in 2022 (%)
Americas is the largest Anticoagulant Drugs market with about 51% market share. Europe is follower, accounting for about 27% market share.The key manufacturers are Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo etc. Top 3 companies occupied about 56% market share.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticoagulants Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticoagulants Drug Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Anticoagulants Drug Market Segment Percentages, by Type, 2022 (%)
- Novel Oral Anticoagulants (NOACs)
- Warfarin (VKA)
- Others
Global Anticoagulants Drug Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Anticoagulants Drug Market Segment Percentages, by Application, 2022 (%)
Global Anticoagulants Drug Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Anticoagulants Drug Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Anticoagulants Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Anticoagulants Drug revenues share in global market, 2022 (%)
- Key companies Anticoagulants Drug sales in global market, 2018-2023 (Estimated), (K Pcs)
- Key companies Anticoagulants Drug sales share in global market, 2022 (%)
key players include:
- C. H. Boehringer Sohn (Germany)
- Bristol-Myers Squibb (US)
- Johnson & Johnson (US)
- Pfizer (US)
- Daiichi Sankyo (Japan)
- Portola Pharmaceuticals (US)
- Roche (Switzerland)
- Abbott (US)
- Siemens (Germany)
- Alere (US)
- CoaguSense (US)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anticoagulants Drug, market overview.
Chapter 2: Global Anticoagulants Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Anticoagulants Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anticoagulants Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anticoagulants Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
